Implications of proposed medicare reforms to counteract high cancer drug prices Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Cost Control
  • Drug Costs
  • Medicare Part B

publication date

  • July 19, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2016.5998

PubMed ID

  • 27149663

Additional Document Info

start page

  • 271

end page

  • 2

volume

  • 316

number

  • 3